Background and Aims: Sphingosine 1-phosphate (S1P) accounts for antiatherogenic properties of high-density
lipoproteins, but the S1P receptor subtype mediating the atheroprotective effects
of S1P and the underlying molecular mechanisms remain enigmatic. Experimental models
engineered to amplify the signaling of endogenous S1P over its specific receptors
may help in clarifying this issue. To this purpose, we generated a mouse model overexpressing
S1P receptor type 1 (S1P1) specifically in the myeloid compartment and studied the effect on atherosclerosis
development.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
030 / #1045 Track 2 - Metabolism of Lipids and Lipoproteins STEROLS AT THE CROSSROAD OF METABOLIC PATHWAYS 10-06-2020 10:00 AM - 11:13 AM
Identification
Copyright
© 2020 Published by Elsevier Inc.
